Faecalibacteriumprausnitzii Is Associated With Clinical Response to Immune Checkpoint Inhibitors in Patients With Advanced Gastric Adenocarcinoma: Results of Microbiota Analysis of PRODIGE 59-FFCD 1707-DURIGAST Trial
| Title: | Faecalibacteriumprausnitzii Is Associated With Clinical Response to Immune Checkpoint Inhibitors in Patients With Advanced Gastric Adenocarcinoma: Results of Microbiota Analysis of PRODIGE 59-FFCD 1707-DURIGAST Trial |
|---|---|
| Authors: | Bredon, Marius, le Malicot, Karine, Louvet, Christophe, Evesque, Ludovic, Gonzalez, Daniel, Tougeron, David ∗, Sokol, Harry ∗ |
| Source: | In Gastroenterology March 2025 168(3):601-603 |
| Database: | ScienceDirect |
| ISSN: | 00165085 |
|---|---|
| DOI: | 10.1053/j.gastro.2024.10.020 |
| Published in: | Gastroenterology |
| Language: | English |